Published in Mol Cell Proteomics on July 17, 2006
Alterations in the serum glycome due to metastatic prostate cancer. J Proteome Res (2007) 2.30
Glycomics and disease markers. Curr Opin Chem Biol (2009) 2.04
Profile of native N-linked glycan structures from human serum using high performance liquid chromatography on a microfluidic chip and time-of-flight mass spectrometry. Proteomics (2009) 1.79
Mass spectrometry and the emerging field of glycomics. Chem Biol (2008) 1.69
High-mannose glycans are elevated during breast cancer progression. Mol Cell Proteomics (2010) 1.63
The development of retrosynthetic glycan libraries to profile and classify the human serum N-linked glycome. Proteomics (2009) 1.52
Mass spectrometry and glycomics. OMICS (2010) 1.47
Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery. Anal Chem (2010) 1.47
Comprehensive native glycan profiling with isomer separation and quantitation for the discovery of cancer biomarkers. Analyst (2011) 1.36
Chemical approaches to perturb, profile, and perceive glycans. Acc Chem Res (2009) 1.33
Glycan reductive isotope labeling for quantitative glycomics. Anal Biochem (2009) 1.31
Plasma membrane proteomics and its application in clinical cancer biomarker discovery. Mol Cell Proteomics (2010) 1.27
Quantitative serum glycomics of esophageal adenocarcinoma and other esophageal disease onsets. J Proteome Res (2009) 1.25
Glycomic profiling of invasive and non-invasive breast cancer cells. Glycoconj J (2008) 1.24
Identifying cancer biomarkers by mass spectrometry-based glycomics. Electrophoresis (2012) 1.19
Development of a robust and high throughput method for profiling N-linked glycans derived from plasma glycoproteins by NanoLC-FTICR mass spectrometry. J Proteome Res (2009) 1.19
Development of a nanoLC LTQ orbitrap mass spectrometric method for profiling glycans derived from plasma from healthy, benign tumor control, and epithelial ovarian cancer patients. Anal Chem (2009) 1.17
Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer. J Proteome Res (2011) 1.14
Glycomic analysis of sialic acid linkages in glycans derived from blood serum glycoproteins. J Proteome Res (2010) 1.13
Stable-isotope labeled hydrophobic hydrazide reagents for the relative quantification of N-linked glycans by electrospray ionization mass spectrometry. Anal Chem (2011) 1.07
Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop. J Natl Cancer Inst (2012) 1.02
Glycan family analysis for deducing N-glycan topology from single MS. Bioinformatics (2008) 1.02
Salmonella Degrades the Host Glycocalyx Leading to Altered Infection and Glycan Remodeling. Sci Rep (2016) 1.00
Analysis of glycan variation on glycoproteins from serum by the reverse lectin-based ELISA assay. J Proteome Res (2014) 1.00
Defining putative glycan cancer biomarkers by MS. Bioanalysis (2012) 0.99
Automated glycopeptide analysis--review of current state and future directions. Brief Bioinform (2012) 0.98
Isomer-specific chromatographic profiling yields highly sensitive and specific potential N-glycan biomarkers for epithelial ovarian cancer. J Chromatogr A (2013) 0.95
Towards an integrated proteomic and glycomic approach to finding cancer biomarkers. Genome Med (2009) 0.94
N-Glycan profiling of dried blood spots. Anal Chem (2011) 0.93
N-Glycan structure annotation of glycopeptides using a linearized glycan structure database (GlyDB). J Proteome Res (2007) 0.93
Microchip electrophoresis of N-glycans on serpentine separation channels with asymmetrically tapered turns. Electrophoresis (2011) 0.92
Glycoproteomics-based identification of cancer biomarkers. Int J Proteomics (2011) 0.92
Glycomic analysis by glycoprotein immobilization for glycan extraction and liquid chromatography on microfluidic chip. Anal Chem (2013) 0.90
N-glycan profiling by microchip electrophoresis to differentiate disease states related to esophageal adenocarcinoma. Anal Chem (2012) 0.89
Comparative profiling of N-glycans isolated from serum samples of ovarian cancer patients and analyzed by microchip electrophoresis. J Proteome Res (2013) 0.88
Serum glycan signatures of gastric cancer. Cancer Prev Res (Phila) (2013) 0.88
Protein modifications as potential biomarkers in breast cancer. Biomark Insights (2009) 0.87
Investigations with O-linked protein glycosylations by matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry. J Mass Spectrom (2008) 0.86
One-Year Plasma N-linked Glycome Intra-individual and Inter-individual Variability in the Chicken Model of Spontaneous Ovarian Adenocarcinoma. Int J Mass Spectrom (2011) 0.85
Structure determination by MALDI-IRMPD mass spectrometry and exoglycosidase digestions of O-linked oligosaccharides from Xenopus borealis egg jelly. Glycobiology (2011) 0.84
The Serum Immunoglobulin G Glycosylation Signature of Gastric Cancer. EuPA Open Proteom (2015) 0.83
The effects of abundant plasma protein depletion on global glycan profiling using nanoLC FT-ICR mass spectrometry. Anal Bioanal Chem (2010) 0.83
Use of activated graphitized carbon chips for liquid chromatography/mass spectrometric and tandem mass spectrometric analysis of tryptic glycopeptides. Rapid Commun Mass Spectrom (2009) 0.83
Glycomic Alterations in the Highly-abundant and Lesser-abundant Blood Serum Protein Fractions for Patients Diagnosed with Hepatocellular Carcinoma. Int J Mass Spectrom (2011) 0.83
Jacalin bound plasma O-glycoproteome and reduced sialylation of alpha 2-HS glycoprotein (A2HSG) in rheumatoid arthritis patients. PLoS One (2012) 0.83
Mass spectrometric screening of ovarian cancer with serum glycans. Dis Markers (2014) 0.83
Biomarkers of Helicobacter pylori-associated gastric cancer. Gut Microbes (2013) 0.82
Glycomic analysis of tear and saliva in ocular rosacea patients: the search for a biomarker. Ocul Surf (2012) 0.82
Liquid chromatography-selected reaction monitoring (LC-SRM) approach for the separation and quantitation of sialylated N-glycans linkage isomers. Anal Chem (2014) 0.82
Relative Quantification and Higher-Order Modeling of the Plasma Glycan Cancer Burden Ratio in Ovarian Cancer Case-Control Samples. J Proteome Res (2015) 0.80
Multiple lectin assays for detecting glyco-alteration of serum GP73 in liver diseases. Glycoconj J (2015) 0.80
A Multichannel Biosensor for Rapid Determination of Cell Surface Glycomic Signatures. ACS Cent Sci (2015) 0.80
Glycopeptide Site Heterogeneity and Structural Diversity Determined by Combined Lectin Affinity Chromatography/IMS/CID/MS Techniques. J Am Soc Mass Spectrom (2015) 0.79
Targeted glycomics by selected reaction monitoring for highly sensitive glycan compositional analysis. Proteomics (2012) 0.79
Quantitative mass spectrometric analysis of glycoproteins combined with enrichment methods. Mass Spectrom Rev (2014) 0.79
Glycans and glycoproteins as specific biomarkers for cancer. Anal Bioanal Chem (2016) 0.79
Complementary Glycomic Analyses of Sera Derived from Colorectal Cancer Patients by MALDI-TOF-MS and Microchip Electrophoresis. Anal Chem (2016) 0.78
Chemoenzymatic method for glycomics: Isolation, identification, and quantitation. Proteomics (2015) 0.78
Laminin α5-derived peptides modulate the properties of metastatic breast tumour cells. Clin Exp Metastasis (2011) 0.78
Applications of Fourier Transform Ion Cyclotron Resonance (FT-ICR) and Orbitrap Based High Resolution Mass Spectrometry in Metabolomics and Lipidomics. Int J Mol Sci (2016) 0.77
Structural Characterization of Serum N-Glycans by Methylamidation, Fluorescent Labeling, and Analysis by Microchip Electrophoresis. Anal Chem (2016) 0.77
Hepatocellular carcinoma markers in the omics era: the glycomic analysis. Hepatobiliary Surg Nutr (2014) 0.76
Disease-specific IgG Fc N-glycosylation as personalized biomarkers to differentiate gastric cancer from benign gastric diseases. Sci Rep (2016) 0.76
Analysis of glycoprotein processing in the endoplasmic reticulum using synthetic oligosaccharides. Proc Jpn Acad Ser B Phys Biol Sci (2012) 0.76
DNA hypomethylation upregulates expression of the MGAT3 gene in HepG2 cells and leads to changes in N-glycosylation of secreted glycoproteins. Sci Rep (2016) 0.75
Identification of potential serum biomarkers for breast cancer using a functional proteomics technology. Biomark Res (2017) 0.75
Is high throughput glycomics possible? Mass Spectrom (Tokyo) (2013) 0.75
Integrated GlycoProteome Analyzer (I-GPA) for Automated Identification and Quantitation of Site-Specific N-Glycosylation. Sci Rep (2016) 0.75
Serum glycoprotein-derived N- and O-linked glycans as cancer biomarkers. Am J Cancer Res (2016) 0.75
Breast cancer and protein biomarkers. World J Exp Med (2012) 0.75
Gold Nanoparticle Based Platforms for Circulating Cancer Marker Detection. Nanotheranostics (2017) 0.75
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature (2004) 5.61
Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection. J Clin Oncol (2010) 4.81
Combinatorial chemistry identifies high-affinity peptidomimetics against alpha4beta1 integrin for in vivo tumor imaging. Nat Chem Biol (2006) 3.22
Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. J Proteome Res (2006) 2.99
Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass. Nat Med (2012) 2.80
The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials (2011) 2.45
A strategy for annotating the human milk glycome. J Agric Food Chem (2006) 2.42
Human milk glycobiome and its impact on the infant gastrointestinal microbiota. Proc Natl Acad Sci U S A (2010) 2.34
Glycoprofiling of bifidobacterial consumption of human milk oligosaccharides demonstrates strain specific, preferential consumption of small chain glycans secreted in early human lactation. J Agric Food Chem (2007) 2.33
In vitro fermentation of breast milk oligosaccharides by Bifidobacterium infantis and Lactobacillus gasseri. Appl Environ Microbiol (2006) 2.21
The minimum element of a synthetic peptide required to block prostate tumor cell migration. Cancer Biol Ther (2006) 2.20
Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases. Cancer Res (2003) 2.11
Frontiers in glycomics: bioinformatics and biomarkers in disease. An NIH white paper prepared from discussions by the focus groups at a workshop on the NIH campus, Bethesda MD (September 11-13, 2006). Proteomics (2008) 2.09
Well-defined, reversible boronate crosslinked nanocarriers for targeted drug delivery in response to acidic pH values and cis-diols. Angew Chem Int Ed Engl (2012) 2.08
Consumption of human milk oligosaccharides by gut-related microbes. J Agric Food Chem (2010) 2.07
Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology (2008) 2.05
Glycomics and disease markers. Curr Opin Chem Biol (2009) 2.04
A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer. Biomaterials (2009) 2.04
Development of an annotated library of neutral human milk oligosaccharides. J Proteome Res (2010) 1.99
From combinatorial chemistry to cancer-targeting peptides. Mol Pharm (2007) 1.98
Well-defined, size-tunable, multifunctional micelles for efficient paclitaxel delivery for cancer treatment. Bioconjug Chem (2010) 1.98
Ion mobility spectrometry-mass spectrometry performance using electrodynamic ion funnels and elevated drift gas pressures. J Am Soc Mass Spectrom (2007) 1.93
Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults. Arch Intern Med (2005) 1.90
Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol (2006) 1.89
Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors. Cancer Cell (2010) 1.88
A novel peptide-based encoding system for "one-bead one-compound" peptidomimetic and small molecule combinatorial libraries. J Am Chem Soc (2002) 1.87
A quantitative and comprehensive method to analyze human milk oligosaccharide structures in the urine and feces of infants. Anal Bioanal Chem (2013) 1.83
p21 is a prognostic marker for renal cell carcinoma: implications for novel therapeutic approaches. J Urol (2007) 1.81
Sweetening the pot: adding glycosylation to the biomarker discovery equation. Clin Chem (2009) 1.81
A human breast cell model of preinvasive to invasive transition. Cancer Res (2008) 1.79
Profile of native N-linked glycan structures from human serum using high performance liquid chromatography on a microfluidic chip and time-of-flight mass spectrometry. Proteomics (2009) 1.79
Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways. Cell Host Microbe (2011) 1.77
"OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo. Cancer Res (2012) 1.75
Therapeutic cancer targeting peptides. Biopolymers (2002) 1.70
An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California. Cancer J (2004) 1.68
Annotation and structural analysis of sialylated human milk oligosaccharides. J Proteome Res (2011) 1.68
Initial characterization of a dedicated breast PET/CT scanner during human imaging. J Nucl Med (2009) 1.68
High-mannose glycans are elevated during breast cancer progression. Mol Cell Proteomics (2010) 1.63
Autophagy Blockade Sensitizes Prostate Cancer Cells towards Src Family Kinase Inhibitors. Genes Cancer (2010) 1.63
Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer. Proc Natl Acad Sci U S A (2006) 1.63
Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623. J Clin Oncol (2007) 1.59
Suppression of the negative regulator LRIG1 contributes to ErbB2 overexpression in breast cancer. Cancer Res (2008) 1.59
Determination of glycosylation sites and site-specific heterogeneity in glycoproteins. Curr Opin Chem Biol (2009) 1.56
The development of retrosynthetic glycan libraries to profile and classify the human serum N-linked glycome. Proteomics (2009) 1.52
Validation: the new challenge for pathology. Toxicol Pathol (2004) 1.50
Properties of bisphosphonates in the 13762 rat mammary carcinoma model of tumor-induced bone resorption. Clin Cancer Res (2003) 1.50
Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery. Biomaterials (2011) 1.50
EMT tumorigenesis in the mouse mammary gland. Lab Invest (2007) 1.47
A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci U S A (2004) 1.47
HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells. Clin Cancer Res (2012) 1.47
Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol (2005) 1.47
In vitro fermentability of human milk oligosaccharides by several strains of bifidobacteria. Mol Nutr Food Res (2007) 1.46
Cloning, sequencing, analysis, and heterologous expression of the fredericamycin biosynthetic gene cluster from Streptomyces griseus. J Am Chem Soc (2005) 1.46
Oblique-incidence reflectivity difference microscope for label-free high-throughput detection of biochemical reactions in a microarray format. Appl Opt (2007) 1.45
The prospects of glycan biomarkers for the diagnosis of diseases. Mol Biosyst (2008) 1.45
ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2. Cancer Res (2010) 1.43
Congo red and thioflavin-T analogs detect Abeta oligomers. J Neurochem (2007) 1.43
A novel size-tunable nanocarrier system for targeted anticancer drug delivery. J Control Release (2010) 1.42
Grade-dependent proteomics characterization of kidney cancer. Mol Cell Proteomics (2009) 1.41
Application of Fourier transform ion cyclotron resonance mass spectrometry to oligosaccharides. Mass Spectrom Rev (2005) 1.41
Glycomic approach for potential biomarkers on prostate cancer: profiling of N-linked glycans in human sera and pRNS cell lines. Dis Markers (2008) 1.41
A cautionary note as to the use of pBi-L and related luciferase/transgenic vectors in the study of thyroid endocrinology. Thyroid (2008) 1.41
Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis. J Autoimmun (2006) 1.41
Direct binding of integrin alphavbeta3 to FGF1 plays a role in FGF1 signaling. J Biol Chem (2008) 1.40
Determination of N-glycosylation sites and site heterogeneity in glycoproteins. Anal Chem (2003) 1.40
Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ. Clin Cancer Res (2006) 1.39
Daily variations in oligosaccharides of human milk determined by microfluidic chips and mass spectrometry. J Agric Food Chem (2007) 1.39
A versatile and scalable strategy for glycoprofiling bifidobacterial consumption of human milk oligosaccharides. Microb Biotechnol (2008) 1.38
Human serum processing and analysis methods for rapid and reproducible N-glycan mass profiling. J Proteome Res (2010) 1.37
In vivo positron-emission tomography imaging of progression and transformation in a mouse model of mammary neoplasia. Proc Natl Acad Sci U S A (2004) 1.37
Rapid resolution of carbohydrate isomers by electrospray ionization ambient pressure ion mobility spectrometry-time-of-flight mass spectrometry (ESI-APIMS-TOFMS). J Am Soc Mass Spectrom (2007) 1.36
Comprehensive native glycan profiling with isomer separation and quantitation for the discovery of cancer biomarkers. Analyst (2011) 1.36
Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes. Mol Cancer Ther (2004) 1.33
From whence will they come? - A perspective on the acute shortage of pathologists in biomedical research. J Vet Diagn Invest (2007) 1.32
Analysis of ribonucleotide reductase M2 mRNA levels in patient samples after GTI-2040 antisense drug treatment. Oncol Rep (2006) 1.32
Comparative pathology of nerve sheath tumors in mouse models and humans. Cancer Res (2004) 1.31
The influence of milk oligosaccharides on microbiota of infants: opportunities for formulas. Annu Rev Food Sci Technol (2011) 1.30
Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth. Cancer Res (2006) 1.30
Applications of one-bead one-compound combinatorial libraries and chemical microarrays in signal transduction research. Acc Chem Res (2003) 1.29
Gas-phase chiral separations by ion mobility spectrometry. Anal Chem (2006) 1.28
Detecting glycan cancer biomarkers in serum samples using MALDI FT-ICR mass spectrometry data. Bioinformatics (2008) 1.28